NCT00246714View on ClinicalTrials.gov

Pathophysiology and Clinical Relevance of Endotoxin Tolerance in Humans

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Endotoxemia
Interventions
DRUG

repeated injections of endotoxin during 5 days

Trial Locations (1)

6500HB

Radboud University Nijmegen Medical Center, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT00246714 - Pathophysiology and Clinical Relevance of Endotoxin Tolerance in Humans | Biotech Hunter | Biotech Hunter